Take away currency benefits of 4.8 percent, and a boost of 2.6 percent from acquisitions, and Sigma-Aldrich’s revenues grew 1.8 percent in the fourth quarter of FY 2004, the company reported this week.

“Market growth made our sales expectations a challenge in 2004 and I expect that it will continue to do so, if to a lesser degree, in 2005,” David Harvey, Sigma’s chairman and CEO, said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.